Ocular Therapeutix
Develops hydrogel-based drug delivery systems for treating eye diseases
biotechpharmaceuticals
Company facts
- Founded
- 2006
- Employees
- 325
- Headquarters
- United States
- Type
- Public
- Listed
- NASDAQ: OCUL
Open positions
1 job
28 views last week
Retina Corporate Accounts Director
Open 29d RemoteNorth AmericaContractSenior 4 questions
United States
Ocular Therapeutix, Inc. (NASDAQ:OCUL) is a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye using its proprietary…
Ccpa Go-to-Market Performance Management